Key result
US national investments in discovery and translational science continue to produce major advances in understanding and treating cardiovascular disease.
Answers are grounded in this paper and cite their sources.
Highlights the ongoing need for cardiovascular clinical research to address the growing population with long-term cardiovascular disease driven by physical inactivity, diabetes, and obesity.
Substantial age-adjusted reductions in cardiovascular mortality and morbidity over the past few decades are being challenged by increases in physical inactivity, diabetes mellitus, and obesity, creating a large and aging population with long-term cardiovascular disease (CVD). However, the US national investments in discovery and translational science1 continue to produce major advances, both in understanding these conditions at the cellular level and in development of therapeutic and diagnostic tools that can improve health outcomes.
No takes yet. Share an insight, caveat, or question.
Califf et al. (2012) conducted an editorial in Cardiovascular disease. US national investments in discovery and translational science continue to produce major advances in understanding and treating cardiovascular disease.
Synapse has enriched 10 related papers. Consider them for comparative context: